Genomic Life Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Genomic Life's estimated annual revenue is currently $12.9M per year.(i)
  • Genomic Life's estimated revenue per employee is $243,000

Employee Data

  • Genomic Life has 53 Employees.(i)
  • Genomic Life grew their employee count by -9% last year.

Genomic Life's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head EngineeringReveal Email/Phone
3
Head Enterprise Business Systems and Business OperationsReveal Email/Phone
4
Head, Clinical ServicesReveal Email/Phone
5
Head Partnerships and ServicesReveal Email/Phone
6
Senior Client ManagerReveal Email/Phone
7
Human Resources ManagerReveal Email/Phone
8
Implementation ManagerReveal Email/Phone
9
Client Experience ManagerReveal Email/Phone
10
Implementation ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is Genomic Life?

keywords:N/A

N/A

Total Funding

53

Number of Employees

$12.9M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genomic Life News

2022-04-20 - The 7-Hour Critical-Care Genome

The 7-Hour Critical-Care Genome. Going from blood sample to diagnosis in the same work shift, rapid genomic sequencing proves its worth in...

2022-04-20 - Igniting A New Genomics Revolution

These extraordinary efforts have led to advances in genomic research and a deeper understanding of its impact on our lives.

2022-04-13 - Genomic Life to Present at Business Group on Health's Annual Conference - Benzinga

NASHVILLE, Tenn. --News Direct--. Genomic Life, a leading genome benefit management company with a mission of providing innovative benefit...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M536%N/A
#2
$6.9M5320%N/A
#3
$6.9M53-16%N/A
#4
$7.4M536%$2.3M
#5
$9.8M538%N/A